Improving the efficiency of RNA interference in mammals

Nature Reviews Genetics

Volumn 5, Issue 5, 2004, Pages 355-365

  Mittal, Vivek ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA;

DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE SILENCING; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; RNA INTERFERENCE;

ANIMALS; GENE EXPRESSION REGULATION; GENE SILENCING; RNA INTERFERENCE;

INVERTEBRATA; MAMMALIA;

EID: 1942499451     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrg1323     Document Type: Review

References (127)

1. Sharp, P. A. RNAi and double-strand RNA. Genes Dev. 13, 139-141 (1999).
2. Hammond, S. M., Caudy, A. A. & Hannon, G. J. Posttranscriptional gene silencing by double-stranded RNA. Nature Rev. Genet. 2, 110-119 (2001).
3. Hannon, G. J. RNA interference. Nature 418, 244-251 (2002).
4. McManus, M. T. & Sharp, P. A. Gene silencing in mammals by small interfering RNAs. Nature Rev. Genet. 3, 737-747 (2002).
5. Dykxhoorn, D. M., Novina, C. D. & Sharp, P. A. Killing the messenger: short RNAs that silence gene expression. Nature Rev. Mol. Cell Biol. 4, 457-467 (2003).
6. Elbashir, S. M., Lendeckei, W. & Tuschl, T. RNA interference is mediated by 21 - and 22-nucleotide RNAs. Genes Dev. 15, 188-200 (2001). Shows for the first time that chemically synthesized short dsRNA molecules of 21-22 nt - known as small interfering RNAs (siRNAs) - could be used to target mammalian genes by RNAi while evading the interferon responses. This was confirmed independently by reference 7.
7. Caplen, N. J., Parrish, S., Imani, F., Fire, A. & Morgan, R. A. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl Acad. Sci. USA. 98, 9742-9747 (2001).
8. Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J. & Conklin, D. S. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16, 948-958 (2002). This work, together with references 9-11 and 53-55, shows that plasmids are cost-effective; they also provide a continuous expression of hairpin RNAs that is useful for analysing loss-of-function phenotypes that develop over extended periods of time.
9. Sui, G. et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl Acad. Sci. USA 99, 5515-5520 (2002).
10. Brummelkamp, T. R. & Bernards, R. New tools for functional mammalian cancer genetics. Nature Rev. Cancer 3, 781-789 (2003).
11. Paul, C. P., Good, P. D., Winer, I. & Engelke, D. R. Effective expression of small interfering RNA in human cells. Nature Biotechnol. 20, 505-508 (2002).
12. Bridge, A. J., Pebernard, S., Ducraux, A., Nicoulaz, A. L. & Iggo, R. Induction of an interferon response by RNAi vectors in mammalian cells. Nature Genet. 34, 263-264 (2003).
13. Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H. & Williams, B. R. Activation of the interferon system by short-interfering RNAs. Nature Cell Biol. 5, 834-839 (2003).
14. Shuey, D. J., McCallus, D. E. & Giordano, T. RNAi: gene-silencing in therapeutic intervention. Drug Discov. Today 7, 1040-1046 (2002).
15. Silva, J. M., Hammond, S. M. & Hannon, G. J. RNA interference: a promising approach to antiviral therapy? Trends Mol. Med. 8, 505-508 (2002).
16. Kim, V. N. RNA interference in functional genomics and medicine. J. Korean Med. Sci. 18, 309-318 (2003).
17. Capecchi, M. R. The new mouse genetics: altering the genome by gene targeting. Trends Genet. 5, 70-76 (1989).
18. Scherer, L. J. & Rossi, J. J. Approaches for the sequence-specific knockdown of mRNA. Nature Biotechnol. 21, 1457-1465 (2003). A review that highlights the use of RNA-based methods such as antisense vectors, catalytic RNA molecules (ribozymes) and catalytic DNA molecules (DNAzymes) to suppress gene expression.
19. Opalinska, J. B. & Gewirtz, A. M. Nucleic-acid therapeutics: basic principles and recent applications. Nature Rev. Drug Discov. 1, 503-514 (2002).
20. Bernstein, E., Caudy, A. A., Hammond, S. M. & Hannon, G. J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363-366 (2001). Describes the identification of the ribonuclease III activity of the evolutionary conserved Dicer enzyme, which is required for processing long dsRNA into 21-22nt fragments (siRNA).
21. Nykanen, A., Haley, B. & Zamore, P. D. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 107, 309-321 (2001).
22. Martinez, J., Patkaniowska, A., Urlaub, H., Luhrmann, R. & Tuschl, T. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110, 563-574 (2002).
23. Doench, J. G., Petersen, C. P. & Sharp, P. A. siRNAs can function as miRNAs. Genes Dev. 17, 438-442 (2003).
24. Zeng, Y., Yi, R. & Cullen, B. R. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc. Natl Acad. Sci. USA 100, 9779-9784 (2003).
25. Elbashir, S. M., Harborth, J., Weber, K. & Tuschl, T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26, 199-213 (2002).
26. Khvorova, A., Reynolds, A. & Jayasena, S. D. Functional siRNAs and miRNAs exhibit strand bias. Cell 115, 209-216 (2003).
27. Schwarz, D. S. et al. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115, 199-208 (2003). References 26 and 27 describe, for the first time, the mechanism of bias in siRNA strand selection that occurs during siRNA-RISC assembly and activation, and that influences the overall efficiency of RNAi. This information has contributed important parameters to the rational design of effective siRNAs.
28. Chiu, Y. L. & Rana, T. M. RNAi in human cells: basic structural and functional features of small interfering RNA. Mol. Cell 10, 549-561 (2002).
29. Chiu, Y. L. & Rana, T. M. siRNA function in RNAi: a chemical modification analysis. RNA 9, 1034-1048 (2003).
30. Reynolds, A. et al. Rational siRNA design for RNA interference. Nature Biotechnol. 22, 326-330 (2004). The authors identified important features that are required to design effective siRNAs by carrying out a systematic analysis of 180 siRNAs that target the mRNAs of two genes.
31. Ui-Tei, K. et al. Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res. 32, 936-948 (2004).
32. Kumar, R., Conklin, D. S. & Mittal, V. High-throughput selection of effective RNAi probes for gene silencing. Genome Res. 13, 2333-2340 (2003).
33. Lee, N. S. et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nature Biotechnol. 20, 500-505 (2002).
34. Yu, J. Y., Taylor, J., DeRuiter, S. L., Vojtek, A. B. & Tumer, D. L. Simultaneous inhibition of GSK3α and GSK3β using hairpin siRNA expression vectors. Mol. Ther. 7, 228-236 (2003).
35. Vickers, T. A. et al. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J. Biol. Chem. 278, 7108-7118 (2003).
36. Kretschmer-Kazemi Far, R. & Sczakiel, G. The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides. Nucleic Acids Res. 31, 4417-4424 (2003).
37. Holen, T., Amarzguioui, M., Wiiger, M. T., Babaie, E. & Prydz, H. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res. 30, 1757-1766 (2002).
38. Bohula, E. A. et al. The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript. J. Biol. Chem. 278, 15991-15997 (2003).
39. Ding, Y. & Lawrence, C. E. A statistical sampling algorithm for RNA secondary structure prediction. Nucleic Acids Res. 31, 7280-7301 (2003).
40. Hemann, M. T. et al. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nature Genet 33, 396-400 (2003).
41. Carpenter, A. E. & Sabatini, D. M. Systematic genome-wide screens of gene function. Nature Rev. Genet. 5, 11-22 (2004).
42. Mousses, S. et al. RNAi microarray analysis in cultured mammalian cells. Genome Res. 13, 2341-2347 (2003).
43. Elbashir, S. M., Martinez, J., Patkaniowska, A., Lendeckel, W. & Tuschl, T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20, 6877-6888 (2001).
44. Tuschl, T., Zamore, P. D., Lehmann, R., Bartel, D. P. & Sharp, P. A. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev. 13, 3191-3197 (1999).
45. Miller, V. M. et al. Allele-specific silencing of dominant disease genes. Proc. Natl Acad. Sci. USA 100, 7195-7200 (2003).
46. Gonzalez-Alegre, P., Miller, V. M., Davidson, B. L. & Paulson, H. L. Toward therapy for DYT1 dystonia: allele-specific silencing of mutant TorsinA. Ann. Neurol. 53, 781-787 (2003).
47. Chi, J. T. et al. Genomewide view of gene silencing by small interfering RNAs. Proc. Natl Acad. Sci. USA 100, 6343-6346 (2003).
48. Semizarov, D. et al. Specificity of short interfering RNA determined through gene expression signatures. Proc. Natl Acad. Sci. USA 100, 6347-6352 (2003).
49. Jackson, A. L. et al. Expression profiling reveals off-target gene regulation by RNAi. Nature Biotechnol. 21, 635-637 (2003). These authors used a DNA microarray approach to measure changes at the mRNA level that result from siRNA-mediated gene silencing. They showed, for the first time, that siRNAs can silence non-targeted genes that have limited sequence similarity to the siRNA.
50. Scacheri, P. C. et al. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc. Natl Acad. Sci. USA 101, 1892-1897 (2004).
51. McManus, M. T. et al. Small interfering RNA-mediated gene silencing in T lymphocytes. J. Immunol. 169, 5754-5760 (2002).
52. Kishida, T. et al. Sequence-specific gene silencing in murine muscle induced by electroporation-mediated transfer of short interfering RNA. J. Gene Med. 6, 105-110 (2004).
53. Miyagishi, M. & Taira, K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nature Biotechnol. 20, 497-500 (2002).
54. McManus, M. T., Petersen, C. P., Haines, B. B., Chen, J. & Sharp, P. A. Gene silencing using micro-RNA designed hairpins. RNA 8, 842-850 (2002).
55. Brummelkamp, T. R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553 (2002).
56. Kawasaki, H. & Taira, K. Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. Nucleic Acids Res. 31, 700-707 (2003).
57. Xia, H., Mao, Q., Paulson, H. L. & Davidson, B. L. siRNA-mediated gene silencing in vitro and in vivo. Nature Biotechnol. 20, 1006-1010 (2002).
58. Shinagawa, T. & Ishii, S. Generation of Ski-knockdown mice by expressing a long double-strand RNA from an RNA polymerase II promoter. Genes Dev. 17, 1340-1345 (2003).
59. Paddison, P. J. & Hannon, G. J. RNA interference: the new somatic cell genetics? Cancer Cell 2, 17-23 (2002).
60. Barton, G. M. & Medzhitov, R. Retroviral delivery of small interfering RNA into primary cells. Proc. Natl Acad. Sci. USA 99, 14943-14945 (2002).
61. Liu, C. M., Liu de, P., Dong, W. J. & Liang, C. C. Retrovirus vector-mediated stable gene silencing in human cell. Biochem. Biophys. Res. Commun. 313, 716-720 (2004).
62. Brummelkamp, T. R., Bernards, R. & Agami, R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2, 243-247 (2002).
63. Rubinson, D. A. et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nature Genet. 33, 401-406 (2003).
64. Stewart, S. A. et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9, 493-501 (2003).
65. Tiscornia, G., Singer, O., Ikawa, M. & Verma, I. M. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl Acad. Sci. USA 100, 1844-1848 (2003).
66. Van den Haute, C., Eggermont, K., Nuttin, B., Debyser, Z. & Baekelandt, V. Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brain. Hum. Gene Ther. 14, 1799-1807 (2003).
67. Scherr, M., Battrner K., Ganser, A. & Eder, M. Modulation of gene expression by lentiviral-mediated delivery of small interfering RNA. Cell Cycle 2, 251-257 (2003).
68. Abbas-Terki, T., Blanco-Bose, W., Deglon, N., Pralong, W. & Aebischer, P. Lentiviral-mediated RNA interference. Hum. Gene Ther. 13, 2197-2201 (2002).
69. Qin, X. F., An, D. S., Chen, I. S. & Baltimore, D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl Acad. Sci. USA 100, 183-188 (2003).
70. Shen, C., Buck, A. K., Liu, X., Winkler, M. & Reske, S. N. Gene silencing by adenovirus-delivered siRNA. FEBS Lett. 539, 111-114 (2003).
71. Arts, G. J. et al. Adenoviral vectors expressing siRNAs for discovery and validation of gene function. Genome Res. 13, 2325-2332 (2003).
72. Pfeifer, A., Ikawa, M., Dayn, Y. & Verma, I. M. Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc. Natl Acad. Sci. USA 99, 2140-2145 (2002).
73. Williams, D. A. & Baum, C. Medicine. Gene therapy - new challenges ahead. Science 302, 400-401 (2003).
74. Hacein-Bey-Abina, S. et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419 (2003).
75. Marshall, E. Gene therapy. Second child in French trial is found to have leukemia. Science 299, 320 (2003).
76. Carmell, M. A., Zhang, L., Conklin, D. S., Hannon, G. J. & Rosenquist, T. A. Germline transmission of RNAi in mice. Nature Struct. Biol. 10, 91-92 (2003).
77. Hasuwa, H., Kaseda, K., Einarsdottir, T. & Okabe, M. Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett. 532, 227-230 (2002).
78. Kunath, T. et al. Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nature Biotechnol. 21, 559-561 (2003).
79. McCaffrey, A. P. et al. RNA interference in adult mice. Nature 418, 38-39 (2002).
80. Lewis, D. L., Hagstrom, J. E., Loomis, A. G., Wolff, J. A. & Herweijer, H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nature Genet. 32, 107-108 (2002).
81. Song, E. et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nature Med. 9, 347-351 (2003).
82. Hommel, J. D., Sears, R. M., Georgescu, D., Simmons, D. L. & DiLeone, R. J. Local gene knockdown in the brain using viral-mediated RNA interference. Nature Med. 9, 1539-1544 (2003).
83. Kile, B. T. et al. Functional genetic analysis of mouse chromosome 11. Nature 425, 81-86 (2003).
84. Kennerdell, J. R. & Carthew, R. W. Heritable gene silencing in Drosophila using double-stranded RNA. Nature Biotechnol. 18, 896-898 (2000).
85. Czauderna, F. et al. Inducible shRNA expression for application in a prostate cancer mouse model. Nucleic Acids Res. 31, e127 (2003).
86. van de Wetering, M. et al. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep. 4, 609-615 (2003).
87. Wiznerowicz, M. & Trono, D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J. Virol. 77, 8957-8961 (2003). Along with references 85, 86, 88, 91 and 92, these authors show that RNAi can be activated in a conditional manner in mammalian systems.
88. Matsukura, S., Jones, P. A. & Takai, D. Establishment of conditional vectors for hairpin siRNA knockdowns. Nucleic Acids Res. 31, e77 (2003).
89. Chen, Y., Stamatoyannopoulos, G. & Song, C. Z. Downregulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res. 63, 4801-4804 (2003).
90. No, D., Yao, T. P. & Evans, R. M. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl Acad. Sci. USA 93, 3346-3351 (1996).
91. Van Craenenbroeck, K., Vanhoenacker, P., Leysen, J. E. & Haegeman, G. Evaluation of the tetracycline- and ecdysone-inducible systems for expression of neurotransmitter receptors in mammalian cells. Eur. J. Neurosci. 14, 968-976 (2001).
92. Gupta, S., Schoer, R. A., Egan, J. E., Hannon, G. J. & Mittal, V. Inducible, reversible and stable RNA interference in mammalian cells. Proc. Natl Acad. Sci. USA 101, 1927-1932 (2004).
93. Stolarov, J. et al. Design of a retroviral-mediated ecdysone-inducible system and its application to the expression profiling of the PTEN tumor suppressor. Proc. Natl Acad. Sci. USA 98, 13043-13048 (2001).
94. Fraser, A. G. et al. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 408, 325-330 (2000).
95. Kamath, R. S. et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421, 231-237 (2003).
96. Lee, S. S. et al. A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nature Genet. 33, 40-48 (2003).
97. Ashrafi, K. et al. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421, 268-272 (2003).
98. Pothof, J. et al. Identification of genes that protect the C. elegans genome against mutations by genome-wide RNAi. Genes Dev. 17, 443-448 (2003).
99. Lum, L. et al. Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells. Science 299, 2039-2045 (2003).
100. Kiger, A. et al. A functional genomic analysis of cell morphology using RNA interference. J. Biol. 2, 27 (2003).
101. Boutros, M. et al. Genome-wide RNAi analysis of growth and viability in Drosophila cells. Science 303, 832-835 (2004).
102. Venter, J. C. et al. The sequence of the human genome. Science 291, 1304-1351 (2001).
103. Lander, E. S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860-921 (2001).
104. Waterston, R. H. et al. Initial sequencing and comparative analysis of the mouse genome. Nature 420, 520-562 (2002).
105. Aza-Blanc, P. et al. Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol. Cell 12, 627-637 (2003).
106. Zheng, L. et al. An approach to genomewide screens of expressed small interfering RNAs in mammalian cells. Proc. Natl Acad. Sci. USA 101, 135-140 (2004).
107. Shirane, D. et al. Enzymatic production of RNAi libraries from cDNAs. Nature Genet. (2004).
108. Sen, G., Wehrman, T. S., Myers, J. W. & Blau, H. M. Restriction enzyme-generated siRNA (REGS) vectors and libraries. Nature Genet. 36, 183-189 (2004).
109. Berns, K. et al. A large-scale RNAi screen in human cells identifies novel components of the p53 pathway. Nature 428, 431-437 (2004). This work, together with reference 127, describes the generation and applications of array-formatted retrovirus-based barcoded shRNA expression libraries that targat human and murine genes.
110. Brummelkamp, T. R., Nijman, S. M., Dirac, A. M. & Bernards, R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature 424, 797-801 (2003).
111. Simmer, F. et al. Genome-wide RNAi of C. elegans using the hypersensitive rrf-3 strain reveals novel gene functions. PLoS Biol. 1, E12 (2003).
112. Ramos-Nino, M. E., Scapoli, L., Martinelli, M., Land, S. & Mossman, B. T. Microarray analysis and RNA silencing link fra-1 to cd44 and c-met expression in mesothelioma. Cancer Res. 63, 3539-3545 (2003).
113. Ruzinova, M. B. et al. Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 4, 277-289 (2003).
114. Harborth, J., Elbashir, S. M., Bechert, K., Tuschl, T. & Weber, K. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci. 114, 4557-4565 (2001).
115. Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498 (2001).
116. Kapadia, S. B., Brideau-Andersen, A. & Chisari, F. V. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc. Natl Acad. Sci. USA 100, 2014-2018 (2003).
117. Calegari, F., Haubensak, W., Yang, D., Huttner, W. B. & Buchholz, F. Tissue-specific RNA interference in postimplantation mouse embryos with endoribonuclease-prepared short interfering RNA. Proc. Natl Acad. Sci. USA 99, 14236-14240 (2002).
118. Kawasaki, H., Suyama, E., Iyo, M. & Taira, K. siRNAs generated by recombinant human Dicer induce specific and significant but target site-independent gene silencing in human cells. Nucleic Acids Res. 31, 981-987 (2003).
119. Myers, J. W., Jones, J. T., Meyer, T. & Ferrell, J. E. Jr. Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing. Nature Biotechnol. 21, 324-328 (2003).
120. Bryom, M., Pallota, V., Brown, D. & Ford, L. Visualizing siRNA in mammalian cells: fluorescence analysis of the RNAi effect. Ambion TechNotes 9, 3-5 (2002).
121. Schwarz, D. S., Hutvagner, G., Haley, B. & Zamore, P. D. Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways. Mol. Cell 10, 537-548 (2002).
122. Kirchner, R., Vogtherr, M., Limmer, S. & Sprinzl, M. Secondary structure dimorphism and interconversion between hairpin and duplex form of oligoribonucleotides. Antisense Nucleic Acid Drug Dev. 8, 507-516 (1998).
123. Holen, T., Amarzguioui, M., Babaie, E. & Prydz, H. Similar behaviour of single-strand and double-strand siRNAs suggests they act through a common RNAi pathway. Nucleic Acids Res. 31, 2401-2407 (2003).
124. Shoemaker, D. D., Lashkari, D. A., Morris, D., Mittmann, M. & Davis, R. W. Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar-coding strategy. Nature Genet. 14, 450-456 (1996).
125. Ziauddin, J. & Sabatini, D. M. Microarrays of cells expressing defined cDNAs. Nature 411, 107-110 (2001).
126. Kim, D. H. et al. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nature Biotechnol. 22, 321-325 (2004).
127. Paddison, P. J. et al. A resource for large-scale RNA-interference-based screens in mammals. Nature 428, 427-431 (2004).